Lisa M Butler

47PUBLICATIONS
263CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyGenomics and transcriptomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Sep 27, 2026
Insulin-Like Growth Factor Axis and Survival in Metastatic Hormone-Sensitive Prostate Cancer: Post-Hoc Analysis From the ENZAMET Phase 3 Trial.

|Jun 02, 2026
USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer.

|Apr 03, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.

Silvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli

|Mar 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Sara Bleve, Francesco Ravera, Silvia Rodrigues

|Mar 03, 2026
Connecting the Cell Cycle to Lipid Metabolism in Cancer: Their Reciprocal Roles and Opportunity for Therapeutic Exploitation.

Joshua T Hodgson, Lisa M Butler, Margaret M Centenera

|Dec 03, 2025
Standardized metrics for assessment and reproducibility of imaging-based spatial transcriptomics datasets.

Jasmine T Plummer, Felipe Segato Dezem, David P Cook

Pageof 8

Frequent Collaborators

10 joint publications

Johannes V Swinnen

10 joint publications

Luke A Selth

9 joint publications

Andrew J Hoy

8 joint publications

Zeyad D Nassar